Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study.
JTO Clin Res Rep
; 4(6): 100514, 2023 Jun.
Article
en En
| MEDLINE
| ID: mdl-37304652
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
JTO Clin Res Rep
Año:
2023
Tipo del documento:
Article